Yan Fu
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
- Oncology 17
- Inflammatory Biomarkers in Disease Prognosis 7
-
- Plant Reproductive Biology 4
- DNA Repair Mechanisms 3
- Co-authors
- Weidong Tong (1 shared paper)Fan Li (1 shared paper)Heling Wang (2 shared papers)Qi Su (2 shared papers)Changjun Yin (10 shared papers)Chao Qin (9 shared papers)Hui Zhao (5 shared papers)Nan Du (5 shared papers)
- Journals
- Medicine (3 papers)Scientific Reports (2 papers)Molecular Carcinogenesis (2 papers)PLoS ONE (2 papers)Journal of the American Society for Horticultural Science (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yan Fu
49 papers receiving 983 citations
Peers
Comparison fields: 5 of 93
- Oncology 499
- Cancer Research 208
- Otorhinolaryngology 59
- Pulmonary and Respiratory Medicine 279
- Hepatology 65
Countries citing papers authored by Yan Fu
This map shows the geographic impact of Yan Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Fu more than expected).
Fields of papers citing papers by Yan Fu
This network shows the impact of papers produced by Yan Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Fu. The network helps show where Yan Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 127 | |
| 2 | 2016 | 93 | |
| 3 | 2013 | 74 | |
| 4 | 2016 | 52 | |
| 5 | 2021 | 52 | |
| 6 | 2012 | 38 | |
| 7 | 2016 | 38 | |
| 8 | Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib. | 2015 | 34 |
| 9 | 2016 | 29 | |
| 10 | 2010 | 27 | |
| 11 | 2012 | 25 | |
| 12 | 2015 | 25 | |
| 13 | 2023 | 24 | |
| 14 | 2010 | 23 | |
| 15 | 2017 | 23 | |
| 16 | 2016 | 23 | |
| 17 | 2019 | 22 | |
| 18 | 2015 | 21 | |
| 19 | 2011 | 21 | |
| 20 | 2019 | 18 |
About Yan Fu
Yan Fu is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 994 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (7 papers), Cancer, Lipids, and Metabolism (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Plant Reproductive Biology (4 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (499 citations), Cancer Research (208 citations), Otorhinolaryngology (59 citations), Pulmonary and Respiratory Medicine (279 citations) and Hepatology (65 citations). Yan Fu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Weidong Tong, Fan Li, Heling Wang, Qi Su, Changjun Yin, Chao Qin, Hui Zhao, Nan Du, Ankui Yang and Xiaosong Li. Their work appears in journals such as Medicine, Scientific Reports, Molecular Carcinogenesis, PLoS ONE and Journal of the American Society for Horticultural Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.